Colon Cancer Prevention Clinical Trial
— M3GOfficial title:
Exploring the Effects of a High Chlorophyll Dietary Intervention to Reduce Colon Cancer Risk in Adults: The Meat and Three Greens Feasibility Trial
Verified date | October 2019 |
Source | Auburn University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Colon cancer is the third most common cancer in men and women and over 70% of cases are
preventable. A western diet, characterized by low vegetable and high red and processed meat
intake, indisputably increases colon cancer risk. Heme, which gives red meat its color, is
highly reactive, induces hyperproliferation and promotes DNA damage in the colon to a greater
degree than any other red meat-associated carcinogen. Preclinical models indicate dietary
chlorophyll, which gives green leafy vegetables their color, binds and stabilizes heme in the
lumen, preventing genotoxicity. Additionally, data from our randomized controlled weight loss
trial indicate increasing red meat consumption has deleterious effects on the gut microbiome,
which is also implicated in colon cancer etiology. Because heme-containing foods are the
richest sources of bioavailable iron and several other vitamins and minerals, mitigating
their potential risks may be more beneficial than eliminating meat, poultry, fish and seafood
in their entirety from the diet for risk reduction.
This feasibility study will begin to explore the research question: Will adding
chlorophyll-rich green leafy vegetables to the diet prevent the deleterious effects of
heme-rich red meat on the human host and microbiome? The investigators will randomly assign
50 adults at increased risk of colorectal adenoma to a block randomized crossover study with
two 4-week dietary regimens in which: 1) participants will be provided with frozen green
leafy vegetables and counseled to consume a high chlorophyll diet including 1 cup per day of
cooked green leafy vegetables and normal meat (high heme) consumption; or 2) continue their
normal high heme, low chlorophyll diet (control). A 4-week washout period encouraging
habitual diet will be employed between the intervention periods and data will be collected at
all four time points.
This study is critical in translating preclinical findings and has the potential to open the
door to new knowledge and standards of care in colon cancer prevention. This study is a
required step to aid in the design of a larger RCT to determine whether increased green leafy
vegetable consumption mitigates the negative effects of red meat on DNA damage, inflammatory
cytokines and gut microbe composition. This could lead to equally beneficial dietary guidance
for colon health that might be more easily attained by the general public through addition,
rather than omission of specific foods.
Status | Completed |
Enrollment | 50 |
Est. completion date | December 12, 2018 |
Est. primary completion date | December 12, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Consume less than 2 servings of green leafy vegetables per day - Consume 5 or more servings of red meat per week - BMI >30 kg/m2 - Agrees to not change dietary supplements during course of study - Willing to comply with dietary regimen over course of study - Able to store and cook frozen green leafy vegetables (freezer and microwave) - Able to speak and read English Exclusion Criteria: - Previous diagnosis of colon cancer - Use of any of the following in the past 4 weeks: systemic antibiotics, corticosteroids, immunosuppressive agents, commercial probiotics |
Country | Name | City | State |
---|---|---|---|
United States | Auburn University | Auburn | Alabama |
Lead Sponsor | Collaborator |
---|---|
Auburn University |
United States,
Frugé AD, Ptacek T, Tsuruta Y, Morrow CD, Azrad M, Desmond RA, Hunter GR, Rais-Bahrami S, Demark-Wahnefried W. Dietary Changes Impact the Gut Microbe Composition in Overweight and Obese Men with Prostate Cancer Undergoing Radical Prostatectomy. J Acad Nutr Diet. 2018 Apr;118(4):714-723.e1. doi: 10.1016/j.jand.2016.10.017. Epub 2016 Dec 15. — View Citation
Frugé AD, Smith KS, Riviere AJ, Demark-Wahnefried W, Arthur AE, Murrah WM, Morrow CD, Arnold RD, Braxton-Lloyd K. Primary Outcomes of a Randomized Controlled Crossover Trial to Explore the Effects of a High Chlorophyll Dietary Intervention to Reduce Colon — View Citation
Frugé AD, Van der Pol W, Rogers LQ, Morrow CD, Tsuruta Y, Demark-Wahnefried W. Fecal Akkermansia muciniphila Is Associated with Body Composition and Microbiota Diversity in Overweight and Obese Women with Breast Cancer Participating in a Presurgical Weight Loss Trial. J Acad Nutr Diet. 2018 Nov 9. pii: S2212-2672(18)30279-X. doi: 10.1016/j.jand.2018.08.164. [Epub ahead of print] — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility - accrual | Accrue 50 participants | 9 months | |
Primary | Feasibility - retention | Retain 90% of sample at crossover and 80% at completion | 12 weeks | |
Primary | Feasibility - adherence | Meet chlorophyll intake goals 90% of days | 4 weeks during intervention phase | |
Secondary | DNA damage | Serum 8-hydroxy-2'-deoxyguanosine | Change from baseline to 4 weeks and 8 weeks to 12 weeks | |
Secondary | Inflammatory marker - C-Reactive Protein | Serum hsCRP | Change from baseline to 4 weeks and 8 weeks to 12 weeks | |
Secondary | Inflammatory marker - Tumor Necrosis Factor-alpha | Serum TNF-alpha | Change from baseline to 4 weeks and 8 weeks to 12 weeks | |
Secondary | Inflammatory marker - Interleukin 6 | Serum IL-6 | Change from baseline to 4 weeks and 8 weeks to 12 weeks | |
Secondary | Gut microbe composition | 16s changes in microbiota alpha diversity | Change from baseline to 4 weeks and 8 weeks to 12 weeks | |
Secondary | Bile acids | Plasma primary and secondary bile acids | Change from baseline to 4 weeks and 8 weeks to 12 weeks | |
Secondary | Body composition | Body fat percentage using Bioelectrical Impedence Analysis | Change from baseline to 4 weeks and 8 weeks to 12 weeks | |
Secondary | Acceptability | Acceptability of the diets will be measured by the Food Acceptability Questionnaire (FAQ) total score. The FAQ is a 10 item questionnaire scored on a 7-point likert scale with total scores ranging from 7-70. | 4 weeks during intervention phase |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03148119 -
Study of QRH-882260 Heptapeptide Application in the Colon
|
Phase 1 | |
Completed |
NCT00668161 -
Effect of Exercise on Biomarkers of Colon Cancer Risk
|
Phase 2/Phase 3 |